Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Dec 22, 2020 3:44pm
108 Views
Post# 32162883

RE:HCQ is a flop, a gimmick

RE:HCQ is a flop, a gimmickAnother one that debunks the HCQ gimmick that plot theorists and libertarians like Bunge promoted without any rigorous scientific grounds.


Major study says HCQ worthless against COVID-19


The results from a trial of 821 non-hospitalized subjects who had been exposed to the virus by someone living in their household or as a healthcare worker or first responder were released Wednesday by researchers at the University of Minnesota who led the trial.

The subjects were followed for two weeks to see if they developed symptoms of COVID-19.

“Approximately 12% of those given hydroxychloroquine developed COVID-19 versus approximately 14% given the vitamin placebo,” the researchers reported. The difference was not statistically significant.

Even if there was a statistical difference,” the researchers wrote, “this would equate to treating 42 persons with hydroxychloroquine in order to prevent one infection.”

They said there” was no further benefit to prevent infection among those who also took zinc or vitamin C,” which are commonly paired with the antimalarials.

<< Previous
Bullboard Posts
Next >>